UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year. The ...
More San Diego County students passed the tests than a year earlier. But performance still ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈